Clinical Trials Logo
  1. Home
  2. T2DM
  3. NCT04544319

Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozin 50/10 mg

T2DM Clinical Trial

Official title:
Clinical Trial to Compare the Pharmacokinetics, Safety and Tolerability of the FDC of Gemigliptin/Dapagliflozin 50/10 mg to Each Component of Gemigliptin 50 mg and Dapagliflozin 10 mg

Clinical Trial Summary

To identify bioequivalence between Fixed-dose Combinations of Gemigliptin/Dapagliflozin 50/10 mg to Each Component of Gemigliptin 50 mg and Dapagliflozin 10 mg

Clinical Trial Description

To identify bioequivalence between Fixed-dose Combinations of Gemigliptin/Dapagliflozin 50/10 mg and each Component of Gemigliptin 50 mg and Dapagliflozin 10 mg Also we identify safety and tolerance of FDC and each component ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04544319
Study type Interventional
Source LG Chem
Contact songyi park
Phone 02-6987-4195
Email songyi-park@lgchem.com
Status Not yet recruiting
Phase Phase 1
Start date October 2020
Completion date July 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05996380 - A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes Phase 1
Recruiting NCT02037100 - Sleep Disordered Breathing and Impaired Glucose Homeostasis in Obese Children N/A
Recruiting NCT03563794 - Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes Phase 4
Completed NCT01990469 - Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin Phase 3
Active, not recruiting NCT05680129 - A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM Phase 3
Active, not recruiting NCT04609631 - Tai Chi for Comorbid Depression in T2DM Patients N/A
Completed NCT05681273 - Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects. Phase 1
Active, not recruiting NCT05680155 - A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients Phase 3
Recruiting NCT03564431 - The Imaging Genetic Study of Type 2 Diabetes and Depression
Recruiting NCT05159882 - Safety and Efficacy of THR-1442 Compared to Dapagliflozin as Add-on Therapy to Metformin in T2DM Phase 3